- 询价
- 2026年01月09日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 相关疾病：
恶性黑色素瘤
- ATCC Number：
CRL-1872™
- 物种来源：
人
- 是否是肿瘤细胞：
1
- 库存：
大量
- 运输方式：
冻存运输
- 年限：
54 years
- 生长状态：
贴壁生长
- 器官来源：
皮肤
| Designations: | A375.S2 | ||
| Biosafety Level: | 1 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | adherent | ||
| Organism: | Homo sapiens | ||
| Morphology: | |
||
| Source: | Organ: skin Disease: malignant melanoma |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Tumorigenic: | Yes | ||
| DNA Profile (STR): | Amelogenin: X CSF1PO: 11,12 D13S317: 11,14 D16S539: 9 D5S818: 12 D7S820: 9 THO1: 8 TPOX: 8,10 vWA: 16,17 |
||
| Age: | 54 years | ||
| Gender: | female | ||
| Comments: | This line was cloned by limiting dilution from the A375 melanoma cell line (see ATCC CRL-1619 ). These cells will eventually die and lyse when cultured in medium containing interleukin-1 (interleukin 1, IL-1) and therefore can be used in a reliable and sensitive growth inhibition assay for IL-1. Sensitivity to IL-1 is maximal when the cells are derived from subconfluent cultures in logarithmic growth. |
||
| Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Temperature: 37.0°C |
||
| Subculturing: | Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended Medium Renewal: Every 2 to 3 days Remove medium, rinse with fresh 0.25% trypsin, 0.03% EDTA solution and let the culture sit at room temperature (or 37C) until cells detach (about 10 minutes). Add fresh medium, aspirate and dispense into new flasks. |
||
| Preservation: | culture medium 95%; DMSO, 5% | ||
| Related Products: | Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003 recommended serum:ATCC 30-2020 parental cell line:ATCC CRL-1619 |
||
| References: | 1773: Onozaki K, et al. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135: 3962-3968, 1985. PubMed: 2415593 1774: Lachman LB, et al. Natural and recombinant human interleukin-1beta is cytotoxic for human melanoma cells. J. Immunol. 136: 3098-3102, 1986. PubMed: 3485680 1775: Nakai S, et al. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem. Biophys. Res. Commun. 154: 1189-1196, 1988. PubMed: 3261584 23218: Giard DJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51: 1417-1423, 1973. PubMed: 4357758 |
||
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Slicer Activity in Drosophila melanogaster S2 Extract
RNA (siRNA) to recognize and silence its targets. Drosophila S2 cell extract is a good source of enzymes and factors that faithfully recapitulate essential steps in RISC assembly and function. In this chapter, we will describe how to prepare
Dicer Assay in Drosophila S2 Cell Extract
) are encoded by some viruses and serve as a strategy to counteract the RNAi-based antiviral immunity. In this chapter, we describe a Dicer activity assay in extracts prepared from Drosophila melanogaster S2 cells. We also introduce a simple procedure to study
Production of Recombinant Antibodies in Drosophila melanogaster S2 Cells
One of the major bottlenecks in antibody discovery for research and therapeutic applications is the need for large quantities of protein in a short amount of time. Here we describe an alternative method using the Drosophila melanogaster S2
技术资料暂无技术资料 索取技术资料
